$30,000 of NOVAVAX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to vaccines"
You can find more data on corporate lobbying on Quiver Quantitative.
NVAX Hedge Fund Activity
We have seen 125 institutional investors add shares of NVAX stock to their portfolio, and 149 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARK WEST ASSET MANAGEMENT LLC removed 2,528,857 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $15,931,799
- UBS GROUP AG added 1,260,028 shares (+55.8%) to their portfolio in Q3 2025, for an estimated $10,924,442
- DEEP TRACK CAPITAL, LP removed 998,542 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,657,359
- ALLIANZ ASSET MANAGEMENT GMBH added 872,987 shares (+162.6%) to their portfolio in Q3 2025, for an estimated $7,568,797
- JUPITER ASSET MANAGEMENT LTD removed 779,802 shares (-88.6%) from their portfolio in Q3 2025, for an estimated $6,760,883
- FARALLON CAPITAL MANAGEMENT LLC added 764,000 shares (+4775.0%) to their portfolio in Q3 2025, for an estimated $6,623,880
- HRT FINANCIAL LP added 630,059 shares (+102.3%) to their portfolio in Q3 2025, for an estimated $5,462,611
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NVAX Analyst Ratings
Wall Street analysts have issued reports on $NVAX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 11/18/2025
- B. Riley Securities issued a "Buy" rating on 11/10/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/28/2025
- B of A Securities issued a "Underperform" rating on 08/20/2025
- Citigroup issued a "Sell" rating on 06/17/2025
To track analyst ratings and price targets for NVAX, check out Quiver Quantitative's $NVAX forecast page.
NVAX Price Targets
Multiple analysts have issued price targets for $NVAX recently. We have seen 7 analysts offer price targets for $NVAX in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Anupam Rama from JP Morgan set a target price of $6.0 on 11/18/2025
- Mayank Mamtani from B. Riley Securities set a target price of $16.0 on 11/10/2025
- Brendan Smith from TD Cowen set a target price of $7.0 on 11/04/2025
- Pete Stavropoulos from Cantor Fitzgerald set a target price of $18.0 on 10/24/2025
- Sean Lee from HC Wainwright & Co. set a target price of $11.0 on 10/23/2025
- Alec Stranahan from B of A Securities set a target price of $7.0 on 08/20/2025
- Geoff Meacham from Citigroup set a target price of $6.0 on 06/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
